Scientists try to 'Clean' donor kidneys of hidden virus before transplant
NCT ID NCT07488481
Summary
This early safety trial tests whether treating donor kidneys with an experimental compound called SYN002 during organ preservation can reduce transmission of cytomegalovirus (CMV) to transplant recipients. The study involves 12 patients receiving kidneys from donors known to carry latent CMV. Researchers will assess whether the treatment is safe and whether it decreases the amount of virus transmitted after transplantation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS (CMV) INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Health Network, Toronto General Hospital, Ajmera Transplant Centre
Toronto, Ontario, M5G 2N2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.